Myths and Misconceptions about Insulin Therapy among Latinos/ Hispanics with Diabetes: A Fresh Look at an Old ProblemRené Rodríguez-Gutiérrez1, Andreina Millan-Ferro2 and Enrique Caballero A2*
- *Corresponding Author:
- Enrique Caballero A
Joslin Diabetes Center, Harvard Medical School
One Joslin Place. Boston, MA 02215, USA
Tel: (617) 226 5914
Fax: (617) 226 5930
E-mail: [email protected]
Received date: July 29, 2014; Accepted date: December 14, 2014; Published date: January 01, 2015
Citation: Gutiérrez RR, Ferro AM, Caballero AE (2015) Myths and Misconceptions about Insulin Therapy among Latinos/Hispanics with Diabetes: A Fresh Look at an Old Problem. J Diabetes Metab 6:482. doi: 10.4172/2155-6156.1000482
Copyright: © 2015 Gutiérrez RR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Purpose: The purpose of this review was to identify the frequency and impact of myths and misconceptions about insulin therapy among Latino patients with diabetes. Myths are part of any culture, but can represent a strong barrier in day-to-day diabetes management.
Methods: Articles from the last 22 years (1992-2014) were searched in MEDLINE, EMBASE, Proquest and the Cochrane Central Register of Controlled Trials. Publications for this review included those that studied Latino or Hispanic patients with diabetes and were related to myths and/or misconceptions about insulin therapy.
Results: Twelve articles about misconceptions and myths related to insulin therapy in Latinos or Hispanics with diabetes met the inclusion criteria. All of them evaluated misconceptions about insulin therapy using different types of interviews and questionnaires. Negative attitudes about insulin therapy were highly prevalent among Latino patients. Many considered that insulin therapy was related to a negative life-style. Most patients feared to initiate insulin therapy and believed insulin was associated with a more advanced stage of diabetes. Blindness, amputation and dialysis were frequently considered a consequence of starting insulin therapy.
Conclusion: Misconceptions and myths about insulin therapy prevail in a large number of Latino/Hispanic patients with diabetes. They constitute important barriers when planning to start insulin therapy and may potentially jeopardize their health. Comprehensive educational programs for Latino patients with diabetes must include sessions to identify and address the presence of these misconceptions. At the same time, all health care providers caring for Latino patients with diabetes must be aware of the high prevalence of these well embedded cultural beliefs